CHEMM Stock Overview
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
ChemoMetec A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.326.40 |
| 52 Week High | kr.910.00 |
| 52 Week Low | kr.301.20 |
| Beta | 1.29 |
| 1 Month Change | -22.25% |
| 3 Month Change | -25.58% |
| 1 Year Change | -46.67% |
| 3 Year Change | -24.79% |
| 5 Year Change | 337.53% |
| Change since IPO | 1,383.64% |
Recent News & Updates
ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Sep 17
A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)
Sep 15Recent updates
ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Sep 17A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)
Sep 15At kr.467, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?
Jun 20With EPS Growth And More, ChemoMetec (CPH:CHEMM) Makes An Interesting Case
Jun 01Here's Why ChemoMetec (CPH:CHEMM) Has Caught The Eye Of Investors
Jan 24If EPS Growth Is Important To You, ChemoMetec (CPH:CHEMM) Presents An Opportunity
Oct 26Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?
Oct 05Does ChemoMetec (CPH:CHEMM) Deserve A Spot On Your Watchlist?
Jul 18Here's Why I Think ChemoMetec (CPH:CHEMM) Is An Interesting Stock
Mar 27Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?
Dec 12Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today
Aug 29Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today
Apr 28ChemoMetec A/S' (CPH:CHEMM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 18ChemoMetec (CPH:CHEMM) Is Growing Earnings But Are They A Good Guide?
Feb 10What Type Of Shareholders Make Up ChemoMetec A/S' (CPH:CHEMM) Share Registry?
Jan 15
Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?
Dec 20ChemoMetec A/S' (CPH:CHEMM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Nov 22Shareholder Returns
| CHEMM | DK Life Sciences | DK Market | |
|---|---|---|---|
| 7D | -14.8% | -3.2% | -1.8% |
| 1Y | -46.7% | -9.0% | 31.7% |
Return vs Industry: CHEMM underperformed the Danish Life Sciences industry which returned -8.8% over the past year.
Return vs Market: CHEMM underperformed the Danish Market which returned 32.6% over the past year.
Price Volatility
| CHEMM volatility | |
|---|---|
| CHEMM Average Weekly Movement | 6.5% |
| Life Sciences Industry Average Movement | 5.7% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in DK Market | 9.2% |
| 10% least volatile stocks in DK Market | 2.5% |
Stable Share Price: CHEMM is more volatile than 75% of Danish stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: CHEMM's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Danish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 167 | Rasmus Kofoed | https://chemometec.com |
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; NucleoCounter SCC-100, a somatic cell counter used to measure the number of somatic cells in a milk sample; and NucleoCounter YC-100, an automated yeast cell counter used to measure the total cell count and viability of yeast cells in suspension.
ChemoMetec A/S Fundamentals Summary
| CHEMM fundamental statistics | |
|---|---|
| Market Cap | kr.5.68b |
| Earnings (TTM) | kr.178.67m |
| Revenue (TTM) | kr.444.40m |
31.8x
P/E Ratio12.8x
P/S RatioIs CHEMM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CHEMM income statement (TTM) | |
|---|---|
| Revenue | kr.444.40m |
| Cost of Revenue | kr.49.01m |
| Gross Profit | kr.395.39m |
| Other Expenses | kr.216.72m |
| Earnings | kr.178.67m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Nov 07, 2023
| Earnings per share (EPS) | 10.27 |
| Gross Margin | 88.97% |
| Net Profit Margin | 40.20% |
| Debt/Equity Ratio | 0.2% |
How did CHEMM perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield58%
Payout RatioDoes CHEMM pay a reliable dividends?
See CHEMM dividend history and benchmarks| ChemoMetec dividend dates | |
|---|---|
| Ex Dividend Date | Oct 13 2023 |
| Dividend Pay Date | Oct 17 2023 |
| Days until Ex dividend | 16 days |
| Days until Dividend pay date | 20 days |
Does CHEMM pay a reliable dividends?
See CHEMM dividend history and benchmarks